Today: 2 February 2026
Subscribe
Browse Category

NASDAQ:MDLN News 17 December 2025 - 18 December 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. (Nasdaq: MDLN) is getting a quick reality check after one of the biggest U.S. IPO debuts in years. After the closing bell on Thursday, December 18, 2025, Medline stock finished the regular session at $39.98 (down 2.49% on the day) and traded around $39.49 in after-hours action, after moving between $38.00 and $41.74 during the day. Investing The…
18 December 2025
·····
Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock—trading on the Nasdaq Global Select Market under the ticker MDLN—is having the kind of debut that makes IPO bankers briefly believe in destiny again. On Wednesday, December 17, 2025, Medline shares opened at $35 after pricing its IPO at $29, then finished the session at $41, a gain of about 41% on day one.…
18 December 2025
·····
Medline IPO: MDLN Debuts on Nasdaq After $6.26 Billion Raise in 2025’s Biggest Global Listing

Medline IPO: MDLN Debuts on Nasdaq After $6.26 Billion Raise in 2025’s Biggest Global Listing

Medline is officially back in the public markets. On Wednesday, December 17, 2025, the Northfield, Illinois-based medical supply powerhouse begins trading on the Nasdaq Global Select Market under the ticker MDLN, following an upsized initial public offering that raised about $6.26 billion—the largest global IPO of 2025. Reuters For Wall Street, the scale of the deal matters. For hospitals and…
17 December 2025
·····

Stock Market Today

  • Gilead Sciences (GILD) Sees 12.5% Hedge Fund Share Increase in Latest 13F Filings
    February 2, 2026, 10:06 AM EST. Gilead Sciences Inc (GILD) was held by 11 of the latest 24 hedge funds in 13F filings for the period ending June 30, 2025. Among these funds, four increased their stakes while three decreased holdings; notably, Carrera Capital Advisors exited GILD entirely. Aggregate holdings of GILD shares among 2,951 funds rose by approximately 12.5%, adding 6.2 million shares from March to June 2025. While 13F filings disclose only long positions, making them an incomplete picture, the overall rise suggests renewed hedge fund interest. Analysts advise monitoring such aggregate data over time for deeper investment insights into stocks like Gilead.
Go toTop